John G Ullman & Associates Inc. Has $6.53 Million Stock Position in Itron, Inc. (NASDAQ:ITRI)

John G Ullman & Associates Inc. trimmed its holdings in Itron, Inc. (NASDAQ:ITRI) by 1.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,132 shares of the scientific and technical instruments company’s stock after selling 667 shares during the period. John G Ullman & Associates Inc. owned about 0.14% of Itron worth $6,530,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Sculptor Capital LP bought a new stake in Itron during the 2nd quarter worth about $5,255,000. UniSuper Management Pty Ltd bought a new stake in shares of Itron during the 1st quarter worth approximately $904,000. Assenagon Asset Management S.A. boosted its holdings in shares of Itron by 7.8% in the 2nd quarter. Assenagon Asset Management S.A. now owns 268,379 shares of the scientific and technical instruments company’s stock valued at $26,559,000 after buying an additional 19,387 shares during the last quarter. Tidal Investments LLC bought a new position in shares of Itron in the 1st quarter valued at about $1,319,000. Finally, Vanguard Group Inc. grew its holdings in Itron by 0.8% during the first quarter. Vanguard Group Inc. now owns 5,701,337 shares of the scientific and technical instruments company’s stock worth $527,488,000 after purchasing an additional 45,909 shares during the period. 96.19% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on ITRI. Robert W. Baird upped their target price on Itron from $123.00 to $132.00 and gave the company an “outperform” rating in a research report on Friday, November 1st. Oppenheimer boosted their target price on shares of Itron from $120.00 to $124.00 and gave the company an “outperform” rating in a research report on Friday, November 1st. TD Cowen raised their price target on shares of Itron from $125.00 to $136.00 and gave the stock a “buy” rating in a research report on Friday, November 1st. BNP Paribas began coverage on shares of Itron in a research note on Thursday, September 5th. They issued an “outperform” rating and a $133.00 price objective for the company. Finally, Roth Mkm increased their target price on shares of Itron from $125.00 to $130.00 and gave the stock a “buy” rating in a research report on Friday, November 1st. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $123.92.

Insider Buying and Selling

In other news, CFO Joan S. Hooper sold 509 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $102.15, for a total value of $51,994.35. Following the sale, the chief financial officer now directly owns 72,338 shares of the company’s stock, valued at $7,389,326.70. The trade was a 0.70 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Thomas Deitrich sold 37,500 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $104.83, for a total value of $3,931,125.00. Following the completion of the sale, the chief executive officer now directly owns 205,276 shares in the company, valued at approximately $21,519,083.08. This represents a 15.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,066 shares of company stock valued at $4,092,737 over the last ninety days. 1.45% of the stock is owned by insiders.

Itron Stock Performance

NASDAQ:ITRI opened at $114.11 on Thursday. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91. The business’s 50-day moving average price is $108.87 and its two-hundred day moving average price is $104.86. The stock has a market cap of $5.15 billion, a P/E ratio of 23.38, a PEG ratio of 0.86 and a beta of 1.46. Itron, Inc. has a twelve month low of $64.96 and a twelve month high of $124.90.

Itron (NASDAQ:ITRI) last released its quarterly earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.71. The business had revenue of $615.46 million for the quarter, compared to the consensus estimate of $596.41 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter last year, the business posted $0.98 earnings per share. As a group, equities analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.